David H. Mack - Oct 18, 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Oct 18, 2023
Transactions value $
$105,156
Form type
4
Date filed
11/13/2023, 04:21 PM
Previous filing
Aug 8, 2023
Next filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $105K +198K +119.91% $0.53* 364K Oct 18, 2023 Direct
transaction PMVP Common Stock Gift $0 -85.3K -23.44% $0.00 279K Nov 10, 2023 Direct
transaction PMVP Common Stock Gift $0 +85.3K +106.63% $0.00 165K Nov 10, 2023 See footnote F1
holding PMVP Common Stock 148K Oct 18, 2023 See footnote F2
holding PMVP Common Stock 57K Oct 18, 2023 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -198K -64.45% $0.00 109K Aug 7, 2023 Common Stock 198K $0.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.